Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Colorado Allergy and Asthma Centers (CAAC) is a premier private healthcare provider specializing in the diagnosis and treatment of allergies, asthma, and immunologic disorders in the Rocky Mountain region. Established in 1972, the practice has grown to become the largest of its kind in the area, operating numerous clinics across the Denver metropolitan area and Northern Colorado. CAAC offers a wide range of clinical services, including allergen immunotherapy, advanced biologic treatments, and comprehensive diagnostic testing for conditions such as food allergies, eczema, and chronic sinusitis. Beyond patient care, the organization maintains a dedicated clinical research division that collaborates with major pharmaceutical companies to conduct Phase 2 through Phase 4 clinical trials. This research focus allows CAAC to provide patients with early access to innovative therapies for respiratory and allergic diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Colorado Allergy and Asthma Centers.